Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
59th of 267 in
Neurosciences
-
33rd of 267 in
Pharmacology & Pharmacy
Contents
Current Neuropharmacology, Volume 14 - Number 1
Editorial
Editorial (Thematic Issue: Epigenetics and Neuro-behavioral Modulations)
, 14(1): 2István Bókkon and Birendra Nath Mallick
DOI: 10.2174/1570159X1401160122124901
Epigenetic Drugs for Multiple Sclerosis
, 14(1): 3 - 9Jacob Peedicayil
DOI: 10.2174/1570159X13666150211001600
Epigenetic Drugs for Multiple Sclerosis
Dysregulation of Acetylation Enzymes Inanimal Models of Psychostimulant use Disorders: Evolving Stories
, 14(1): 10 - 16Jean Lud Cadet
DOI: 10.2174/1570159X13666150121230133
Dysregulation of Acetylation Enzymes Inanimal Models of Psychostimulant use Disorders: Evolving Stories
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
, 14(1): 17 - 27Francesco Paolo Busardò, Chrystalla Kyriakou, Luigi Cipolloni, Simona Zaami and Paola Frati
DOI: 10.2174/1570159X13666150407225902
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular
, 14(1): 28 - 40Rachna Mehta, Abhishek Singh, Istvan Bokkon and Birendra Nath Mallick
DOI: 10.2174/1570159X13666150414185737
REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review
, 14(1): 41 - 47Francesco Matrisciano, Isabella Panaccione, Danis R. Grayson, Ferdinando Nicoletti and Alessandro Guidotti
DOI: 10.2174/1570159X13666150713174242
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review
Epigenetics in Brain Tumors: HDACs Take Center Stage
, 14(1): 48 - 54Ilker Y. Eyüpoglu and Nicolai E. Savaskan
DOI: 10.2174/1570159X13666151030162457
Epigenetics in Brain Tumors: HDACs Take Center Stage
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
, 14(1): 55 - 71Shabir Ahmad Ganai, Mahalakshmi Ramadoss and Vijayalakshmi Mahadevan
DOI: 10.2174/1570159X13666151021111609
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Compartmentalized Platforms for Neuro-Pharmacological Research
, 14(1): 72 - 86Amol D. Jadhav, Li Wei and Peng Shi
DOI: 10.2174/1570159X13666150516000957
Compartmentalized Platforms for Neuro-Pharmacological Research
Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models
, 14(1): 87 - 100M. Carmen Arenas, María A. Aguilar, Sandra Montagud-Romero, Ana Mateos-García, Concepción I. Navarro-Francés, José Miñarro and Marta Rodríguez-Arias
DOI: 10.2174/1570159X13666150921112841
Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models
Alzheimer's disease: Targeting the Cholinergic System
, 14(1): 101 - 115Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva and Fabiola M. Ribeiro
DOI: 10.2174/1570159X13666150716165726
Alzheimer's disease: Targeting the Cholinergic System
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
View Full Editorial Board
University College London
Institute of Ophthalmology
London EC1V9EL
UK
Biography
Biography of T.E. Salt
Professor Tom Salt obtained his Degrees from The Universities of Cambridge and Bristol, is co-founder and Director of Neurexpert Ltd, and Emeritus Professor at University College London. He has worked in the pharmaceutical industry, and acted as a consultant and adviser to industry.
Professor Salt's research encompasses the pharmacology of neurotransmitters in relation to the sensory system systems, and more recently the functional consequences of neurodegeneration. He has published over 200 research and review papers, and is a member of several editorial boards and Editor in Chief of "Current Neuropharmacology"
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current Editor-in-Chief serving since 2003.
Scopus CiteScore Metrics: 2.17
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net